Literature DB >> 17602795

Haplotype-specific expression of the N-terminal exons 2 and 3 at the human MAPT locus.

Tara M Caffrey1, Catharine Joachim, Richard Wade-Martins.   

Abstract

The microtubule-associated protein tau (MAPT) H1 haplotype shows a strong association to the sporadic neurodegenerative diseases, progressive supranuclear palsy and corticobasal degeneration. The functional biological mechanisms behind the genetic association have started to emerge with differences recently shown in haplotype splicing of the neuropathologically relevant exon 10. Here we investigate the hypothesis that expression of the alternatively spliced N-terminal exons also differs between the two MAPT haplotypes. We performed allele-specific gene expression analysis on a H1/H2 heterozygous human neuronal cell line model and 14 H1/H2 heterozygous human post-mortem brain tissues from two brain regions. In both cell culture and post-mortem brain tissue, we show that the protective MAPT H2 haplotype significantly expresses two-fold more 2N (exons 2+3+) MAPT transcripts than the disease-associated H1 haplotype. We suggest that inclusion of exon 3 in MAPT transcripts may contribute to protecting H2 carries from neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602795      PMCID: PMC2801070          DOI: 10.1016/j.neurobiolaging.2007.05.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  36 in total

1.  Projection domains of MAP2 and tau determine spacings between microtubules in dendrites and axons.

Authors:  J Chen; Y Kanai; N J Cowan; N Hirokawa
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

2.  Developmentally regulated expression of specific tau sequences.

Authors:  K S Kosik; L D Orecchio; S Bakalis; R L Neve
Journal:  Neuron       Date:  1989-04       Impact factor: 17.173

3.  Hyperphosphorylated tau proteins differentiate corticobasal degeneration and Pick's disease.

Authors:  V Buée Scherrer; P R Hof; L Buée; B Leveugle; P Vermersch; D P Perl; C W Olanow; A Delacourte
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

4.  Epitope expression and hyperphosphorylation of tau protein in corticobasal degeneration: differentiation from progressive supranuclear palsy.

Authors:  M B Feany; H Ksiezak-Reding; W K Liu; I Vincent; S H Yen; D W Dickson
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Domains of tau protein and interactions with microtubules.

Authors:  N Gustke; B Trinczek; J Biernat; E M Mandelkow; E Mandelkow
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

6.  Ultrastructure and biochemical composition of paired helical filaments in corticobasal degeneration.

Authors:  H Ksiezak-Reding; K Morgan; L A Mattiace; P Davies; W K Liu; S H Yen; K Weidenheim; D W Dickson
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

7.  Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau.

Authors:  M Goedert; C M Wischik; R A Crowther; J E Walker; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

9.  Mutation in the tau gene in familial multiple system tauopathy with presenile dementia.

Authors:  M G Spillantini; J R Murrell; M Goedert; M R Farlow; A Klug; B Ghetti
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

10.  Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain.

Authors:  R Brandt; J Léger; G Lee
Journal:  J Cell Biol       Date:  1995-12       Impact factor: 10.539

View more
  36 in total

Review 1.  Current Understanding of Neurodegenerative Diseases Associated With the Protein Tau.

Authors:  Keith A Josephs
Journal:  Mayo Clin Proc       Date:  2017-08       Impact factor: 7.616

2.  Tau isoform composition influences rate and extent of filament formation.

Authors:  Qi Zhong; Erin E Congdon; Haikady N Nagaraja; Jeff Kuret
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

3.  Tau Protein and Frontotemporal Dementias.

Authors:  Michel Goedert; Maria Grazia Spillantini; Benjamin Falcon; Wenjuan Zhang; Kathy L Newell; Masato Hasegawa; Sjors H W Scheres; Bernardino Ghetti
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Protective Variants in Alzheimer's Disease.

Authors:  Shea J Andrews; Brian Fulton-Howard; Alison Goate
Journal:  Curr Genet Med Rep       Date:  2019-01-24

5.  Physiological transgene regulation and functional complementation of a neurological disease gene deficiency in neurons.

Authors:  Pier Paolo Peruzzi; Sean E Lawler; Steve L Senior; Nina Dmitrieva; Pauline A H Edser; Davide Gianni; E Antonio Chiocca; Richard Wade-Martins
Journal:  Mol Ther       Date:  2009-04-07       Impact factor: 11.454

6.  The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.

Authors:  Daphne Robakis; Etty Cortes; Lorraine N Clark; Jean Paul G Vonsattel; Tuhin Virmani; Roy N Alcalay; John F Crary; Oren A Levy
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

7.  H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence.

Authors:  Elliot C Nelson; Arpana Agrawal; Michele L Pergadia; Jen C Wang; John B Whitfield; F Scott Saccone; Jason Kern; Julia D Grant; Andrew J Schrage; John P Rice; Grant W Montgomery; Andrew C Heath; Alison M Goate; Nicholas G Martin; Pamela A F Madden
Journal:  Addict Biol       Date:  2010-01       Impact factor: 4.280

8.  A Polymorphic Antioxidant Response Element Links NRF2/sMAF Binding to Enhanced MAPT Expression and Reduced Risk of Parkinsonian Disorders.

Authors:  Xuting Wang; Michelle R Campbell; Sarah E Lacher; Hye-Youn Cho; Ma Wan; Christopher L Crowl; Brian N Chorley; Gareth L Bond; Steven R Kleeberger; Matthew Slattery; Douglas A Bell
Journal:  Cell Rep       Date:  2016-04-14       Impact factor: 9.423

9.  Genetics: The MAPT locus-a genetic paradigm in disease susceptibility.

Authors:  Richard Wade-Martins
Journal:  Nat Rev Neurol       Date:  2012-09       Impact factor: 42.937

10.  MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.

Authors:  Daniah Trabzuni; Selina Wray; Jana Vandrovcova; Adaikalavan Ramasamy; Robert Walker; Colin Smith; Connie Luk; J Raphael Gibbs; Allissa Dillman; Dena G Hernandez; Sampath Arepalli; Andrew B Singleton; Mark R Cookson; Alan M Pittman; Rohan de Silva; Michael E Weale; John Hardy; Mina Ryten
Journal:  Hum Mol Genet       Date:  2012-06-20       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.